Just published ‼️
10 recommendations for marketing authorisation holders, wholesalers, distributors or manufacturers of #medicines 💊 to prevent and manage medicine #shortages and their impact. 👇
https://www.ema.europa.eu/en/news/guidance-industry-prevent-mitigate-medicine-shortages
🐦🔗: https://n.respublicae.eu/EMA_News/status/1658849848177598465
RT @EFSA_EU: Our commitment to food safety is unwavering. 🥦
In the 🇪🇺, we adhere to some of the world's most stringent food safety standards, ensuring your confidence in dietary choices. Regardless of your preferences, we prioritise your safety.
👉 https://campaigns.efsa.europa.eu/EUChooseSafeFood/#/index-eu
#EUChooseSafeFood https://t.co/Bn25IrhiP5
🐦🔗: https://n.respublicae.eu/EMA_News/status/1658485767554076672
Our annual report 2022 is out!
You can find:
👉 EMA's key achievements, high-impact activities & challenges
👉 an interactive timeline of 2022 milestones
👉key figures on the evaluation & monitoring of 💊
https://www.ema.europa.eu/en/news/ema-annual-report-2022-published
🐦🔗: https://n.respublicae.eu/EMA_News/status/1658366678617473027
RT @SKyriakidesEU: The 🌍response to #COVID19 led to strong progress in health innovation ➡️ vaccine development & distribution and digital health.
We must use this momentum to strengthen future preparedness, deliver better healthcare for our citizens and tackle threats such as #AMR.
#G7JPN https://t.co/LDfZXZHuFG
🐦🔗: https://n.respublicae.eu/EMA_News/status/1658008406186250240
At its monthly meeting, EMA's safety committee, the PRAC, started a review of medicines 💊containing #hydroxyprogesterone and issued a reminder on the restrictions in the use of fluoroquinolone #antibiotics.
More information below 👇
🐦🔗: https://n.respublicae.eu/EMA_News/status/1657022453464330250
On #InternationalNursesDay, we want to thank #nurses for their contribution to our work.
We need more well-trained and well-supported nurses to make sure all the #medicines we assess and approve are used correctly by #patients 🧑⚕️💊
🐦🔗: https://n.respublicae.eu/EMA_News/status/1657012099153817600
RT @WHO: @DrTedros 🚨 BREAKING 🚨
"I have accepted that advice, and am pleased to declare that #mpox is no longer a global health emergency"-@DrTedros
https://t.co/MAZi0HgFjq https://t.co/fuBQDwrdhX
🐦🔗: https://n.respublicae.eu/EMA_News/status/1656673287500627968
RT @EFSA_EU: 🐝 #PollinatorHealth | 📢 We just published our updated guidance document on the #RiskAssessment of #pesticides and #bees.
Read the full story and find out more 👇
https://www.efsa.europa.eu/en/news/bees-and-pesticides-updated-guidance-assessing-risks https://t.co/incOBannly
🐦🔗: https://n.respublicae.eu/EMA_News/status/1656664035906158597
RT @Eurosurveillanc: Protecting the #health of #Europeans through close collaboration
This #EuropeDay2023 learn in our editorial series featuring
⭐️@SandraGallina
⭐️Emer Cooke, @EMA_News
⭐️Pierre Delsaux, @EC_HERA &
⭐️@ECDC_EU's Andrea Ammon
what the 🇪🇺 #HealthUnion means
https://www.eurosurveillance.org/content/public-health-preparedness https://t.co/yEqnMndf8N
🐦🔗: https://n.respublicae.eu/EMA_News/status/1656201783054573571
🕊️Happy #EuropeDay!
🇪🇺 Today #EUAgencies are celebrating the peace and unity that binds us together as EU citizens.
👥 Let’s continue to work together to ensure a peaceful and prosperous future for all.
#EUAgencies #EuropeanUnion
🐦🔗: https://n.respublicae.eu/EMA_News/status/1655831970109349888
Read the statement from our Executive Director, Emer Cooke, on the end of the #COVID19 public health emergency declared last week by @DrTedros.👇
https://www.ema.europa.eu/en/news/statement-emer-cooke-end-covid-19-public-health-emergency
🐦🔗: https://n.respublicae.eu/EMA_News/status/1655586008384122884
RT @EU_HaDEA: Exchange of knowledge on diagnosis and treatment of rare diseases can improve the quality of life of patients
The 2023 #HorizonEU #health call dedicated to the European Partnership on #rarediseases is still open!
📅Apply by 19 September 2023
https://hadea.ec.europa.eu/calls-proposals_en?f[0]=oe_call_proposals_opening_date%3Alt%7C2023-03-01T13%3A02%3A27%2B01%3A00&f[1]=oe_call_proposals_status%3Aupcoming&f[2]=programmes_programme%3A52 https://t.co/5UBV5NNhNB
🐦🔗: https://n.respublicae.eu/EMA_News/status/1655499917052243970
RT @EU_Careers: 🎓 Challenging opportunities are coming up at @EMA_News! 💊 In the coming weeks, #EMA will publish #traineeship placements for the 2023 intake.
Don't miss a chance to work for every patient in Europe ⬇️ https://careers.ema.europa.eu/lp/Traineeship2023/c2cf73fad5d7a389/?locale=en_GB&previewLink=true&overrideEmployeeLogin=false&referrerSave=false
#EUCareers #eujobs #traineeship https://t.co/6KESDguiwb
🐦🔗: https://n.respublicae.eu/EMA_News/status/1654479486761549827
All approved #biosimilars in the 🇪🇺 are interchangeable 💊.
But it is important that #patients and healthcare professionals carefully read the product information before interchanging a biosimilar treatment.
https://www.ema.europa.eu/en/human-regulatory/overview/biosimilar-medicines-overview
Learn more in this video ⬇️
🐦🔗: https://n.respublicae.eu/EMA_News/status/1654381412362117121
RT @EU_HaDEA: If you are working in IT services for #PublicHealth, do not miss this #EU4Health #tender opportunity:
Creation of the IT system on Advanced Technology for Health INtelligence and Action (ATHINA) to rapidly respond to health threats.
💶€23 900 000
📅 23/06
https://hadea.ec.europa.eu/news/call-tenders-hera-creation-advanced-technology-health-intelligence-and-action-it-system-athina-2023-04-25_en https://t.co/78789tTOqL
🐦🔗: https://n.respublicae.eu/EMA_News/status/1654045407670935552
RT @EC_HERA: HERA has an important role in bringing MCMs to the market in the fight against #AMR
The study findings expect HERA's role to:
⬅️Coordinate implementation of pull incentives
➡️Contribute to financial push incentives
🔃 Ensure knowledge sharing
👉https://health.ec.europa.eu/latest-updates/bringing-amr-medical-countermeasures-market-new-study-2023-05-03_en https://t.co/DpRmGsCN8N
🐦🔗: https://n.respublicae.eu/EMA_News/status/1654023730421440512
We restart the publication of #clinicaldata for all medicines 💊 as of Sept '23.
‼️Save the date for a webinar we are organising to guide pharma industry, including small & medium-sized enterprises, on the submission of clinical data for publication. https://www.ema.europa.eu/en/events/clinical-data-publication-policy-0070-re-launch-ema-webinar
🐦🔗: https://n.respublicae.eu/EMA_News/status/1654018123211718657
📢New public consultation open!
EMA is launching a public consultation to review the transparency rules for the publication of information on #clinicaltrials submitted through the Clinical Trials Information System in the 🇪🇺.
🐦🔗: https://n.respublicae.eu/EMA_News/status/1653756835034193920
RT @UMCGlobalSafety: 🎉 We're celebrating 30 years of #pharmacovigilance training! Since 1993, our face-to-face PV course has brought together over 600 professionals from around the globe to strengthen PV through capacity building.
Read what past participants had to say about the course below 👇 https://t.co/Fj2BprTChG
🐦🔗: https://n.respublicae.eu/EMA_News/status/1653710770708922369
RT @EU_HaDEA: #AMR is responsible for an estimated 33 000 deaths per year in the EU
#HaDEA has published a #EU4Health study on bringing #AMR medical countermeasures to the market. The report sheds light on the key role @EC_HERA plays in addressing this challenge.
➡ https://op.europa.eu/en/publication-detail/-/publication/51b2c82c-c21b-11ed-8912-01aa75ed71a1/language-en/format-PDF/source-282347876 https://t.co/TxlWvlqG4b
🐦🔗: https://n.respublicae.eu/EMA_News/status/1653312341759471616
Unofficial automated mirror. No copyright asserted. ∎ Latest news from the European Medicines Agency, the European Union agency responsible for the evaluation and supervision of medicines. RTs ≠ endorsement.